Subclinical Atrial Fibrillation in Older Patients

被引:192
作者
Healey, Jeff S. [1 ,2 ]
Alings, Marco [3 ,4 ]
Ha, Andrew [5 ]
Leong-Sit, Peter [6 ]
Birnie, David H. [7 ]
de Graaf, Jacob J. [8 ]
Freericks, Michel [9 ]
Verma, Atul [5 ]
Wang, Jia [1 ,2 ]
Leong, Darryl [1 ,2 ]
Dokainish, Hisham [1 ,2 ]
Philippon, Francois [10 ]
Barake, Walid [11 ]
McIntyre, William F. [2 ]
Simek, Kim [1 ]
Hill, Michael D. [12 ]
Mehta, Shamir R. [1 ,2 ]
Carlson, Mark [13 ]
Smeele, Frank [14 ]
Pandey, A. Shekhar [2 ,15 ]
Connolly, Stuart J. [1 ,2 ]
机构
[1] Populat Hlth Res Inst, Hamilton, ON, Canada
[2] McMaster Univ, Hamilton, ON, Canada
[3] Amphia Ziekenhuis, Breda, Netherlands
[4] WCN Dutch Network Cardiovasc Res, Toronto, ON, Canada
[5] Univ Toronto, Toronto, ON, Canada
[6] Univ Western Ontario, London, ON, Canada
[7] Univ Ottawa, Heart Inst, Ottawa, ON, Canada
[8] Nij Smellinghe Hosp, Drachten, Netherlands
[9] Ikazia Ziekenhuis, Rotterdam, Netherlands
[10] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada
[11] Univ Alberta, Edmonton, AB, Canada
[12] Univ Calgary, Calgary, AB, Canada
[13] St Jude Med, Sylmar, CA USA
[14] Slingeland Ziekenhuis, Doetinchem, Netherlands
[15] Cambridge Cardiac Care Ctr, Cambridge, ON, Canada
基金
加拿大健康研究院;
关键词
atrial fibrillation; monitoring; physiologic; stroke; RISK; STROKE;
D O I
10.1161/CIRCULATIONAHA.117.028845
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Long-term continuous electrocardiographic monitoring shows a substantial prevalence of asymptomatic, subclinical atrial fibrillation (SCAF) in patients with pacemakers and patients with cryptogenic stroke. Whether SCAF is also common in other patients without these conditions is unknown. METHODS: We implanted subcutaneous electrocardiographic monitors (St. Jude CONFIRM-AF) in patients >= 65 years of age attending cardiovascular or neurology outpatient clinics if they had no history of atrial fibrillation but had any of the following: CHA(2)DS(2)-VASc score of >= 2, sleep apnea, or body mass index > 30 kg/m(2). Eligibility also required either left atrial enlargement (>= 4.4 cm or volume >= 58 mL) or increased (>= 290 pg/mL) serum NT-proBNP (N-terminal pro-B-type natriuretic peptide). Patients were monitored for SCAF lasting >= 5 minutes. RESULTS: Two hundred fifty-six patients were followed up for 16.3 +/- 3.8 months. Baseline age was 74 +/- 6 years; mean CHA(2)DS(2)-VASc score was 4.1 +/- 1.4; left atrial diameter averaged 4.7 +/- 0.8 cm; and 48% had a prior stroke, transient ischemic attack, or systemic embolism. SCAF >= 5 minutes was detected in 90 patients (detection rate, 34.4%/y; 95% confidence interval [CI], 27.7-42.3). Baseline predictors of SCAF were increased age (hazard ratio [HR] per decade, 1.55; 95% CI, 1.11-2.15), left atrial dimension (HR per centimeter diameter, 1.43; 95% CI, 1.09-1.86), and blood pressure (HR per 10 mm Hg, 0.87; 95% CI, 0.78-0.98), but not prior stroke. The rate of occurrence of SCAF in those with a history of stroke, systemic embolism, or transient ischemic attack was 39.4%/y versus 30.3%/y without (P=0.32). The cumulative SCAF detection rate was higher (51.9%/y) in those with left atrial volume above the median value of 73.5 mL. CONCLUSIONS: SCAF is frequently detected by continuous electrocardiographic monitoring in older patients without a history of atrial fibrillation who are attending outpatient cardiology and neurology clinics. Its clinical significance is unclear.
引用
收藏
页码:1276 / +
页数:12
相关论文
共 17 条
  • [1] Patterns of treatment effects in subsets of patients in clinical trials
    Bonetti, M
    Gelber, RD
    [J]. BIOSTATISTICS, 2004, 5 (03) : 465 - 481
  • [2] Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events
    Botto, Giovanni L.
    Padeletti, Luigi
    Santini, Massimo
    Capucci, Alessandro
    Gulizia, Michele
    Zolezzi, Francesco
    Favale, Stefano
    Molon, Giulio
    Ricci, Renato
    Biffi, Mauro
    Russo, Giovanni
    Vimercati, Marco
    Corbucci, Giorgio
    Boriani, Giuseppe
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2009, 20 (03) : 241 - 248
  • [3] Atrial high-rate episodes and stroke prevention
    Camm, A. John
    Simantirakis, Emmanuel
    Goette, Andreas
    Lip, Gregory Y. H.
    Vardas, Panos
    Calvert, Melanie
    Chlouverakis, Gregory
    Diener, Hans-Christoph
    Kirchhof, Paulus
    [J]. EUROPACE, 2017, 19 (02): : 169 - 179
  • [4] Atrial Fibrillation in Patients with Cryptogenic Stroke
    Gladstone, David J.
    Spring, Melanie
    Dorian, Paul
    Panzov, Val
    Thorpe, Kevin E.
    Hall, Judith
    Vaid, Haris
    O'Donnell, Martin
    Laupacis, Andreas
    Cote, Robert
    Sharma, Mukul
    Blakely, John A.
    Shuaib, Ashfaq
    Hachinski, Vladimir
    Coutts, Shelagh B.
    Sahlas, Demetrios J.
    Teal, Phil
    Yip, Samuel
    Spence, J. David
    Buck, Brian
    Verreault, Steve
    Casaubon, Leanne K.
    Penn, Andrew
    Selchen, Daniel
    Jin, Albert
    Howse, David
    Mehdiratta, Manu
    Boyle, Karl
    Aviv, Richard
    Kapral, Moira K.
    Mamdani, Muhammad
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (26) : 2467 - 2477
  • [5] The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk The TRENDS Study
    Glotzer, Taya V.
    Daoud, Emile G.
    Wyse, D. George
    Singer, Daniel E.
    Ezekowitz, Michael D.
    Hilker, Christopher
    Miller, Clayton
    Qi, Dongfeng
    Ziegler, Paul D.
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2009, 2 (05) : 474 - 480
  • [6] Subclinical Atrial Fibrillation and the Risk of Stroke
    Healey, Jeff S.
    Connolly, Stuart J.
    Gold, Michael R.
    Israel, Carsten W.
    Van Gelder, Isabelle C.
    Capucci, Alessandro
    Lau, C. P.
    Fain, Eric
    Yang, Sean
    Bailleul, Christophe
    Morillo, Carlos A.
    Carlson, Mark
    Themeles, Ellison
    Kaufman, Elizabeth S.
    Hohnloser, Stefan H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (02) : 120 - 129
  • [7] The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation A Review
    Hess, Paul L.
    Healey, Jeff S.
    Granger, Christopher B.
    Connolly, Stuart J.
    Ziegler, Paul D.
    Alexander, John H.
    Kowey, Peter R.
    Ruff, Christian T.
    Flaker, Greg
    Halperin, Jonathan L.
    Hart, Robert G.
    Lopes, Renato D.
    [J]. JAMA CARDIOLOGY, 2017, 2 (03) : 324 - 331
  • [8] Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060
    Krijthe, Bouwe P.
    Kunst, Anton
    Benjamin, Emelia J.
    Lip, Gregory Y. H.
    Franco, Oscar H.
    Hofman, Albert
    Witteman, Jacqueline C. M.
    Stricker, Bruno H.
    Heeringa, Jan
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (35) : 2746 - 2751
  • [9] Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
    Lang, Roberto M.
    Badano, Luigi P.
    Mor-Avi, Victor
    Afilalo, Jonathan
    Armstrong, Anderson
    Ernande, Laura
    Flachskampf, Frank A.
    Foster, Elyse
    Goldstein, Steven A.
    Kuznetsova, Tatiana
    Lancellotti, Patrizio
    Muraru, Denisa
    Picard, Michael H.
    Rietzschel, Ernst R.
    Rudski, Lawrence
    Spencer, Kirk T.
    Tsang, Wendy
    Voigt, Jens-Uwe
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2015, 28 (01) : 1 - U170
  • [10] The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines
    Macle, Laurent
    Cairns, John A.
    Andrade, Jason G.
    Mitchell, L. Brent
    Nattel, Stanley
    Verma, Atul
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2015, 31 (10) : 1207 - 1218